Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials

Journal of Immunological Methods

Volumn 322, Issue 1-2, 2007, Pages 57-69

  Bull, Marta ^a   Lee, Deborah ^b   Stucky, Jason ^b   Chiu, Ya Lin ^b   Rubin, Abbe ^b   Horton, Helen ^b,c   McElrath, M Juliana ^b,c  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cryopreservation; IFN gamma; T cells

Indexed keywords

EDETIC ACID; GAMMA INTERFERON; HEPARIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANTICOAGULATION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; ISOLATION PROCEDURE; NONHUMAN; PATIENT MONITORING; PATIENT SELECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VACCINATION; VEIN PUNCTURE;

AIDS VACCINES; BLOOD; CLINICAL TRIALS; CRYOPRESERVATION; CYTOKINES; FEMALE; FREEZING; HIV ANTIGENS; HUMANS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MALE; SPECIMEN HANDLING; T-LYMPHOCYTES;

EID: 34147176167     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2007.02.003     Document Type: Article

References (27)

1. Bach M.K., and Brashler J.R. Isolation of subpopulations of lymphocytic cells by the use of isotonically balanced solutions of Ficoll. I. Development of methods and demonstration of the existence of a large but finite number of subpopulations. Exp. Cell Res. 61 (1970) 387
2. Beattie T., Kaul R., Rostron T., Dong T., Easterbrook P., Jaoko W., Kimani J., Plummer F., McMichael A., and Rowland-Jones S. Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes. Aids 18 (2004) 1595
3. Betensky R.A., Connick E., Devers J., Landay A.L., Nokta M., Plaeger S., Rosenblatt H., Schmitz J.L., Valentine F., Wara D., Weinberg A., and Lederman H.M. Shipment impairs lymphocyte proliferative responses to microbial antigens. Clin. Diagn. Lab. Immunol. 7 (2000) 759
4. Betts M.R., Price D.A., Brenchley J.M., Lore K., Guenaga F.J., Smed-Sorensen A., Ambrozak D.R., Migueles S.A., Connors M., Roederer M., Douek D.C., and Koup R.A. The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration. J. Immunol. 172 (2004) 6407
5. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol., Suppl. 5 (1976) 9
6. Currier J.R., Kuta E.G., Turk E., Earhart L.B., Loomis-Price L., Janetzki S., Ferrari G., Birx D.L., and Cox J.H. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J. Immunol. Methods 260 (2002) 157
7. Hilleman M.R. Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. Vaccine 18 (2000) 1436
8. Hudgens M.G., Self S.G., Chiu Y.L., Russell N.D., Horton H., and McElrath M.J. Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials. J. Immunol. Methods 288 (2004) 19
9. Jin X., Bauer D.E., Tuttleton S.E., Lewin S., Gettie A., Blanchard J., Irwin C.E., Safrit J.T., Mittler J., Weinberger L., Kostrikis L.G., Zhang L., Perelson A.S., and Ho D.D. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189 (1999) 991
10. Koup R.A., Safrit J.T., Cao Y., Andrews C.A., McLeod G., Borkowsky W., Farthing C., and Ho D.D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68 (1994) 4650
11. Kumar A., Weiss W., Tine J.A., Hoffman S.L., and Rogers W.O. ELISPOT assay for detection of peptide specific interferon-gamma secreting cells in rhesus macaques. J. Immunol. Methods 247 (2001) 49
12. Kumar P., and Satchidanandam V. Ethyleneglycol-bis-(beta-aminoethylether)tetraacetate as a blood anticoagulant: preservation of antigen-presenting cell function and antigen-specific proliferative response of peripheral blood mononuclear cells from stored blood. Clin. Diagn. Lab. Immunol. 7 (2000) 578
13. Maecker H.T., Rinfret A., D'Souza P., Darden J., Roig E., Landry C., Hayes P., Birungi J., Anzala O., Garcia M., Harari A., Frank I., Baydo R., Baker M., Holbrook J., Ottinger J., Lamoreaux L., Epling C.L., Sinclair E., Suni M.A., Punt K., Calarota S., El-Bahi S., Alter G., Maila H., Kuta E., Cox J., Gray C., Altfeld M., Nougarede N., Boyer J., Tussey L., Tobery T., Bredt B., Roederer M., Koup R., Maino V.C., Weinhold K., Pantaleo G., Gilmour J., Horton H., and Sekaly R.P. Standardization of cytokine flow cytometry assays. BMC Immunol. 6 (2005) 13
14. Matano T., Shibata R., Siemon C., Connors M., Lane H.C., and Martin M.A. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72 (1998) 164
15. McCutcheon M., Wehner N., Wensky A., Kushner M., Doan S., Hsiao L., Calabresi P., Ha T., Tran T.V., Tate K.M., Winkelhake J., and Spack E.G. A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. J. Immunol. Methods 210 (1997) 149
16. Nanan R., Rauch A., Kampgen E., Niewiesk S., and Kreth H.W. A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J. Gen. Virol. 81 (2000) 1313
17. Nicholson J.K., and Green T.A. Selection of anticoagulants for lymphocyte immunophenotyping. Effect of specimen age on results. J. Immunol. Methods 165 (1993) 31
18. Nicholson J.K., Jones B.M., Cross G.D., and McDougal J.S. Comparison of T and B cell analyses on fresh and aged blood. J. Immunol. Methods 73 (1984) 29
19. Russell N.D., Hudgens M.G., Ha R., Havenar-Daughton C., and McElrath M.J. Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. J. Infect. Dis. 187 (2003) 226
20. Scheibenbogen C., Romero P., Rivoltini L., Herr W., Schmittel A., Cerottini J.C., Woelfel T., Eggermont A.M., and Keilholz U. Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial. J. Immunol. Methods 244 (2000) 81
21. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., Racz P., Tenner-Racz K., Dalesandro M., Scallon B.J., Ghrayeb J., Forman M.A., Montefiori D.C., Rieber E.P., Letvin N.L., and Reimann K.A. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283 (1999) 857
22. Self S.G., Hudgens M.G., Chiu Y.L., and Rossini A.J. Statistical methods for evaluating ELISpot assays in HIV vaccine trials (Abstract). AIDS Vaccine 2001 (2001)
23. Shalekoff S., Page-Shipp L., and Tiemessen C.T. Effects of anticoagulants and temperature on expression of activation markers CD11b and HLA-DR on human leukocytes. Clin. Diagn. Lab. Immunol. 5 (1998) 695
24. Sun Y., Iglesias E., Samri A., Kamkamidze G., Decoville T., Carcelain G., and Autran B. A systematic comparison of methods to measure HIV-1 specific CD8 T cells. J. Immunol. Methods 272 (2003) 23
25. Trigona W.L., Clair J.H., Persaud N., Punt K., Bachinsky M., Sadasivan-Nair N., Dubey S., Tussey L., Fu T.M., and Shiver J. Intracelluar staining for HIV-specific IFN-gamma production: statistical analyses establish reproducibility criteria for distinguishing positive responses. J. Interferon Cytokine Res. 23 7 (2003) 369
26. Weinberg A., Betensky R.A., Zhang L., and Ray G. Effect of shipment, storage, anticoagulant, and cell separation on lymphocyte proliferation assays for human immunodeficiency virus-infected patients. Clin. Diagn. Lab. Immunol. 5 (1998) 804
27. Yasutomi Y., Reimann K.A., Lord C.I., Miller M.D., and Letvin N.L. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67 (1993) 1707